Found: 16
Select item for more details and to access through your institution.
Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3- d ]pyrimidine, Xanthine and Lumazine Derivatives.
- Published in:
- Molecules, 2020, v. 25, n. 21, p. 5205, doi. 10.3390/molecules25215205
- By:
- Publication type:
- Article
A Novel Synthesis of Fused Uracils: Indenopyrimidopyridazines, Pyrimidopyridazines, and Pyrazolopyrimidines for Antimicrobial and Antitumor Evalution.
- Published in:
- Molecules, 2016, v. 21, n. 12, p. 1714, doi. 10.3390/molecules21121714
- By:
- Publication type:
- Article
Novel 2-Thioxanthine and Dipyrimidopyridine Derivatives: Synthesis and Antimicrobial Activity.
- Published in:
- Molecules, 2015, v. 20, n. 10, p. 19263, doi. 10.3390/molecules201019263
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12416, doi. 10.3390/ijms241512416
- By:
- Publication type:
- Article
Synthesis, In Silico Prediction and In Vitro Evaluation of Antimicrobial Activity, DFT Calculation and Theoretical Investigation of Novel Xanthines and Uracil Containing Imidazolone Derivatives.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10979, doi. 10.3390/ijms222010979
- By:
- Publication type:
- Article
Synthesis, DNA Binding and Antiviral Activity of New Uracil, Xanthine, and Pteridine Derivatives.
- Published in:
- Archiv der Pharmazie, 2007, v. 340, n. 1, p. 26
- By:
- Publication type:
- Article
In vitro antimicrobial evaluation and in silico studies of coumarin derivatives tagged with pyrano-pyridine and pyrano-pyrimidine moieties as DNA gyrase inhibitors.
- Published in:
- Molecular Diversity, 2022, v. 26, n. 1, p. 341, doi. 10.1007/s11030-021-10224-4
- By:
- Publication type:
- Article
Synthesis, Molecular Docking and Anticancer Activity of Some 5‐Aryl‐5,10‐dihydropyrido[2,3‐d:6,5‐d′]dipyrimidine‐2,4,6,8‐tetraone Derivatives and Pyrido[2,3‐d]pyrimidines.
- Published in:
- ChemistrySelect, 2022, v. 7, n. 7, p. 1, doi. 10.1002/slct.202103834
- By:
- Publication type:
- Article
Synthesis and anticancer evaluation of some novel pyrimido[5,4-e][1,2,4]triazines and pyrazolo[3,4-d]pyrimidine using DMF-DMA as methylating and cyclizing agent.
- Published in:
- Chemistry Central Journal, 2018, v. 12, n. 1, p. 1, doi. 10.1186/s13065-018-0424-3
- By:
- Publication type:
- Article
Erratum to: One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines.
- Published in:
- Chemistry Central Journal, 2017, v. 11, n. 1, p. 1, doi. 10.1186/s13065-017-0302-4
- By:
- Publication type:
- Article
One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines.
- Published in:
- Chemistry Central Journal, 2017, v. 11, n. 1, p. 1, doi. 10.1186/s13065-017-0294-0
- By:
- Publication type:
- Article
Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1303, doi. 10.3390/ph16091303
- By:
- Publication type:
- Article
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 7, p. 966, doi. 10.3390/ph16070966
- By:
- Publication type:
- Article
Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAF V600E.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 5, p. 716, doi. 10.3390/ph16050716
- By:
- Publication type:
- Article
Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline–Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 494, doi. 10.3390/ph15050494
- By:
- Publication type:
- Article
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 376, doi. 10.3390/ph15030376
- By:
- Publication type:
- Article